Literature DB >> 16260691

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: a commentary.

Judith Abrams.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16260691     DOI: 10.1200/JCO.2005.03.6186

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Prognostic models for stage I-III esophageal cancer: a comparison between existing calculators.

Authors:  Riccardo Lemini; Tamara Díaz Vico; Denslow A Trumbull; Kristopher Attwood; Aaron C Spaulding; Enrique F Elli; Dorin T Colibaseanu; Moshim Kukar; Emmanuel Gabriel
Journal:  J Gastrointest Oncol       Date:  2021-10

2.  Beyond Composite Endpoints Analysis: Semicompeting Risks as an Underutilized Framework for Cancer Research.

Authors:  Ina Jazić; Deborah Schrag; Daniel J Sargent; Sebastien Haneuse
Journal:  J Natl Cancer Inst       Date:  2016-07-05       Impact factor: 13.506

3.  Surrogate endpoints for overall survival in digestive oncology trials: which candidates? A questionnaires survey among clinicians and methodologists.

Authors:  Nicolas Methy; Laurent Bedenne; Franck Bonnetain
Journal:  BMC Cancer       Date:  2010-06-10       Impact factor: 4.430

4.  Stage II-III colon cancer: a comparison of survival calculators.

Authors:  Riccardo Lemini; Kristopher Attwood; Stacey Pecenka; Juliet Grego; Aaron C Spaulding; Steven Nurkin; Dorin T Colibaseanu; Emmanuel Gabriel
Journal:  J Gastrointest Oncol       Date:  2018-12

5.  Low-Level Microsatellite Instability as a Potential Prognostic Factor in Sporadic Colorectal Cancer.

Authors:  Soo Young Lee; Duck-Woo Kim; Hye Seung Lee; Myong Hoon Ihn; Heung-Kwon Oh; Byung Soh Min; Woo Ram Kim; Jung Wook Huh; Jung-A Yun; Kang Young Lee; Nam Kyu Kim; Woo Yong Lee; Hee Cheol Kim; Sung-Bum Kang
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.